𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome

✍ Scribed by Renée C. Niessen; Robert M. W. Hofstra; Helga Westers; Marjolijn J. L. Ligtenberg; Krista Kooi; Paul O. J. Jager; Marloes L. de Groote; Trijnie Dijkhuizen; Maran J. W. Olderode-Berends; Harry Hollema; Jan H. Kleibeuker; Rolf H. Sijmons

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
355 KB
Volume
48
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

It was shown that Lynch syndrome can be caused by germline hypermethylation of the MLH1 and MSH2 promoters. Furthermore, it has been demonstrated very recently that germline deletions of the 3′ region of EPCAM cause transcriptional read‐through which results in silencing of MSH2 by hypermethylation. We wanted to determine the prevalence of germline MLH1 promoter hypermethylation and of germline and somatic MSH2 promoter hypermethylation in a large group of Lynch syndrome‐suspected patients. From a group of 331 Lynch Syndrome‐suspected patients we selected cases, who had no germline MLH1, MSH2, or MSH6 mutation and whose tumors showed loss of MLH1 or MSH2, or, if staining was unavailable, had a tumor with microsatellite instability. Methylation assays were performed to test these patients for germline MLH1 and/or MSH2 promoter hypermethylation. Two patients with germline MLH1 promoter hypermethylation and no patients with germline MSH2 promoter hypermethylation were identified. In the subgroup screened for germline MSH2 promoter hypermethylation, we identified 3 patients with somatic MSH2 promoter hypermethylation in their tumors, which was caused by a germline EPCAM deletion. In the group of 331 Lynch Syndrome‐suspected patients, the frequencies of germline MLH1 promoter hypermethylation and somatic MSH2 promoter hypermethylation caused by germline EPCAM deletions are 0.6 and 0.9%, respectively. These mutations, therefore, seem to be rather infrequent. However, the contribution of germline MLH1 hypermethylation and EPCAM deletions to the genetically proven Lynch syndrome cases in this cohort is very high. Previously 27 pathogenic mutations were identified; the newly identified mutations now represent 16% of all mutations. © 2009 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Recurrence and variability of germline E
Recurrence and variability of germline EPCAM deletions in Lynch syndrome
✍ Roland P. Kuiper; Lisenka E.L.M. Vissers; Ramprasath Venkatachalam; Danielle Bod 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB 👁 1 views

Recently, we identified 3' end deletions in the EPCAM gene as a novel cause of Lynch syndrome. These truncating EPCAM deletions cause allele-specific epigenetic silencing of the neighboring DNA mismatch repair gene MSH2 in tissues expressing EPCAM. Here we screened a cohort of unexplained Lynch-like

Genomic deletions in MSH2 or MLH1 are a
Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: Identification of novel and recurrent deletions by MLPA
✍ C.F. Taylor; R.S. Charlton; J. Burn; E. Sheridan; G.R. Taylor 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Gene dosage abnormalities account for a significant proportion of the mutations in genes tested in DNA diagnostic laboratories. Detection of these changes has proved a challenge as the methods available to date are time consuming or unreliable. The multiplex ligation-dependent probe assay (MLPA) is

Germline hypermethylation of the APC pro
Germline hypermethylation of the APC promoter is not a frequent cause of familial adenomatous polyposis in APC/MUTYH mutation negative families
✍ Jordi Romero-Giménez; Higinio Dopeso; Ignacio Blanco; Angel Guerra-Moreno; Sara 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 226 KB 👁 2 views

## Abstract Familial adenomatous polyposis (FAP) is an autosomal dominant syndrome predisposing to colorectal cancer and affects 1 in 5–10,000 births. Inheritance of a mutant allele of the adenomatous polyposis coli (__APC__) gene is the cause of ∼80% of FAP and 20–30% of an attenuated form of FAP